Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -258,355 | 88,131 | 14,458,910 | 185,179 | 65,215 |
| Depreciation Amortization | 142,517 | 154,848 | 84,629 | 3,799 | 4,579 |
| Income taxes - deferred | 76,324 | -83,010 | 265,096 | -11,227 | -5,685 |
| Accounts receivable | 82,147 | 289,600 | -710,355 | -128,016 | -40,191 |
| Other Working Capital | 277,906 | -1,081,188 | 460,615 | 282,795 | -28,227 |
| Other Operating Activity | -216,542 | -139,126 | 793,645 | 146,779 | 43,383 |
| Operating Cash Flow | $103,997 | $-770,745 | $15,352,540 | $479,309 | $39,074 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -77,126 | -31,847 |
| PPE Investments | -144,504 | -393,192 | -719,651 | -127,466 | -10,607 |
| Net Acquisitions | N/A | 114,352 | N/A | N/A | N/A |
| Purchase Of Investment | -8,355,772 | -11,763,900 | -8,840,274 | N/A | N/A |
| Sale Of Investment | 5,575,287 | 6,327,521 | 6,567,491 | N/A | N/A |
| Purchase Sale Intangibles | -1,145 | -9,568 | -154 | -164 | N/A |
| Other Investing Activity | 876 | -45,251 | -31,140 | -164 | 0 |
| Investing Cash Flow | $-2,924,113 | $-5,760,470 | $-3,023,574 | $-204,756 | $-42,454 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 243,395 | 151 | 13,511 | 33,227 | 2,109 |
| Debt Issued | N/A | N/A | 7,119 | 10,162 | 1,457 |
| Debt Repayment | -4,245 | -1,486 | -13,332 | -4,345 | N/A |
| Common Stock Issued | 676 | N/A | 1,033 | 1,999 | N/A |
| Dividend Paid | -328,080 | -263,171 | -1,875,892 | N/A | N/A |
| Other Financing Activity | 12,191 | 23,107 | -29,119 | 551,523 | -1,829 |
| Financing Cash Flow | $-76,063 | $-241,399 | $-1,896,680 | $592,566 | $1,737 |
| Exchange Rate Effect | -114,901 | -560,769 | 137,269 | 27,207 | -649 |
| Beginning Cash Position | 4,286,377 | 11,619,760 | 1,050,204 | 155,878 | 158,170 |
| End Cash Position | 1,275,297 | 4,286,377 | 11,619,760 | 1,050,204 | 155,878 |
| Net Cash Flow | $-3,011,080 | $-7,333,383 | $10,569,560 | $894,326 | $-2,292 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103,997 | -770,745 | 15,352,540 | 479,309 | 39,074 |
| Capital Expenditure | -144,543 | -393,800 | -719,823 | -127,486 | -10,628 |
| Free Cash Flow | -40,546 | -1,164,545 | 14,632,717 | 351,823 | 28,446 |